Register August 2017 No. 740
Chapter Phar 7
PHARMACY PRACTICE
Phar 7.01   Minimum procedures for compounding and dispensing.
Phar 7.015   Pharmacy technicians.
Phar 7.02   Prescription label; name of drug or drug product dispensed.
Phar 7.03   Prescription renewal limitations.
Phar 7.04   Return or exchange of health items.
Phar 7.05   Prescription records.
Phar 7.055   Transfer of prescription order information.
Phar 7.065   Answering machines in pharmacies.
Phar 7.07   Medication profile record system.
Phar 7.08   Prescription orders transmitted electronically.
Phar 7.09   Automated dispensing systems.
Phar 7.095   Operation of remote dispensing sites.
Phar 7.10   Administration of drug products and devices other than vaccines.
Phar 7.12   Central fill pharmacy.
Phar 7.01 Phar 7.01Minimum procedures for compounding and dispensing.
Phar 7.01(1)(1) Except as provided in sub. (4), a pharmacist or pharmacist-intern who compounds or dispenses according to a prescription order shall follow the procedures described in this rule and other applicable procedures. The pharmacist or pharmacist-intern as directed and supervised by a pharmacist shall:
Phar 7.01(1)(a) (a) Receive electronic or oral prescription orders of a prescriber, review all original and renewal prescription orders, whether electronic, written or oral, and determine therapeutic compatibility and legality of the prescription order. The review shall include, when indicated or appropriate, consultation with the prescriber.
Phar 7.01(1)(b) (b) Read and interpret a prescriber's directions for use for the purpose of accurately transferring the instructions to the prescription label.
Phar 7.01(1)(c) (c) Select, compound, mix, combine, measure, count and otherwise prepare drugs needed to dispense a prescription except that an agent of the pharmacist may procure, measure or count prefabricated dosage forms if a pharmacist verifies accuracy of the agent's action.
Phar 7.01(1)(d) (d) Make a final check on the accuracy and correctness of the prescription. For all original and renewed prescriptions, the prescription order record shall identify the pharmacist responsible for the prescription.
Phar 7.01(1)(e) (e) Give the patient or agent appropriate consultation relative to the prescription except that prescriptions may be delivered by an agent of the pharmacist to a location of the patient's choice if the delivery is accompanied by appropriate directions and an indication that consultation is available by contacting the pharmacist. The consultation requirement applies to original and renewal prescription orders and, except when prescriptions are delivered to a location of the patient's choice, is not satisfied by only offering to provide consultation.
Phar 7.01(1)(em) (em) Transfer the prescription to the patient or agent of the patient.
Phar 7.01(1)(f) (f) Receive, when required by law and standard professional practice, permission to renew from authorized prescribers, and note on the prescription order, medication profile record or uniformly maintained and readily retrievable document the following information:
Phar 7.01(1)(f)1. 1. Date renewed.
Phar 7.01(1)(f)2. 2. Name of practitioner authorizing renewal, if different from the original prescriber.
Phar 7.01(1)(f)3. 3. Quantity of drug dispensed.
Phar 7.01(1)(f)4. 4. Identification of the pharmacist renewing the prescription.
Phar 7.01(2) (2)Subsection (1) (d) and (e) does not prohibit institutional pharmacists or community pharmacists serving institutions from receiving prescription orders, dispensing and returning prescription medications consistent with accepted inpatient institutional drug distribution systems. Subsection (1) applies to any institutional pharmacy dispensing to outpatients, including prescriptions for discharged patients.
Phar 7.01(3) (3) A pharmacist may supervise no more than one pharmacy intern and 4 pharmacy technicians engaged in compounding and dispensing activities as described in sub. (1), except a higher ratio may be authorized by the board upon request to and approval by the board of a specific plan describing the manner in which additional interns or pharmacy technicians shall be supervised.
Phar 7.01(4) (4) A system for compounding and dispensing not in conformance with subs. (1) to (3) may be used if reviewed and approved by the board.
Phar 7.01 History History: Cr. Register, January, 1983, No. 325, eff. 2-1-83; am. (1) (intro.), (d) and (f) (intro.), Register, August, 1991, No. 428, eff. 9-1-91; am. (1) (e), Register, January, 1996, No. 481, eff. 2-1-96; am. (1) (a), (e), (f) (intro)., (3) and cr. (1) (em), Register, December, 1998, No. 516, eff. 1-1-99; am. (1) (a), Register, November, 1999, No. 527, eff. 12-1-99; am. (3), Register, April, 2001, No. 544, eff. 5-1-01; CR 13-018: am. (1) (e) Register October 2013 No. 694, eff. 11-1-13.
Phar 7.015 Phar 7.015Pharmacy technicians.
Phar 7.015(1) (1) As used in this section, “pharmacy technician" means a non-pharmacist or non-pharmacist intern who, under the general supervision of a pharmacist who regularly coordinates, directs and inspects the activities of the pharmacy technician, assists the pharmacist in the technical and nonjudgmental functions related to the practice of pharmacy in the processing of prescription orders and inventory management. “Pharmacy technician" does not include ancillary persons which include, clerks, secretaries, cashiers or delivery persons, who may be present in the pharmacy.
Phar 7.015(2) (2) A pharmacist may delegate technical dispensing functions to a pharmacy technician, but only under the general supervision of the pharmacist where the delegated functions are performed. Technical dispensing functions include:
Phar 7.015(2)(a) (a) Accepting written or electronic prescription orders of the prescribing practitioner or from the prescribing practitioner's agent.
Phar 7.015(2)(b) (b) Accepting original oral prescription orders from the prescribing practitioner or prescribing practitioner's agent, if the conversation is recorded and listened to and verified by the pharmacist prior to dispensing.
Phar 7.015(2)(c) (c) Requesting authorization for a refill from the prescribing practitioner.
Phar 7.015(2)(d) (d) Accepting oral authorization for a refill from the prescribing practitioner or prescribing practitioner's agent, provided there are no changes to the original prescription order.
Phar 7.015(2)(e) (e) Accepting a request from a patient to refill a prescription.
Phar 7.015(2)(f) (f) Obtaining and entering patient or prescription data into the patient information system.
Phar 7.015(2)(g) (g) Preparing a prescription label.
Phar 7.015(2)(h) (h) Retrieving medication from stock, counting or measuring medication, and placing the medication in its final container.
Phar 7.015(2)(i) (i) Reconstituting prefabricated dosage forms.
Phar 7.015(2)(j) (j) Compounding pharmaceuticals pursuant to written policies and procedures.
Phar 7.015(2)(k) (k) Affixing a prescription label to its final container.
Phar 7.015(2)(L) (L) Placing ancillary information on the prescription label.
Phar 7.015(2)(m) (m) Prepackaging and labeling drugs for dispensing by a pharmacist.
Phar 7.015(2)(n) (n) Preparing unit dose carts for final review by a pharmacist.
Phar 7.015(2)(o) (o) Retrieving and transporting stock medication to and from pharmacist approved areas.
Phar 7.015(2)(p) (p) Other technical functions that do not require the professional judgment of a pharmacist.
Phar 7.015(2)(q) (q) Transferring the prescription to the patient or agent of the patient, provided that the pharmacist has first provided a patient consultation.
Phar 7.015(3) (3) A pharmacy technician may not do any of the following:
Phar 7.015(3)(a) (a) Provide the final verification for the accuracy, validity, completeness, or appropriateness of a filled prescription or medication order.
Phar 7.015(3)(b) (b) Perform any of the following tasks:
Phar 7.015(3)(b)1. 1. Participate in final drug utilization reviews.
Phar 7.015(3)(b)2. 2. Make independent therapeutic alternate drug selections.
Phar 7.015(3)(b)3. 3. Participate in final drug regimen screening, including screening for therapeutic duplication, drug-to-drug interactions, incorrect dosage, incorrect duration of treatment, drug allergy reactions and clinical abuse or misuse.
Phar 7.015(3)(b)4. 4. Perform any act necessary to be a managing pharmacist.
Phar 7.015(3)(b)5. 5. Administer any prescribed drug products, devices or vaccines.
Phar 7.015(3)(c) (c) Provide patient counseling, consultation, or patient specific judgment, such as interpreting or applying information, including advice relating to therapeutic values, potential hazards and uses.
Phar 7.015(4) (4) The pharmacist shall provide the final verification for the accuracy, validity, completeness, and appropriateness of the patient's prescription prior to the delivery of the prescription to the patient or the patient's representative.
Phar 7.015 History History: Cr. Register, April, 2001, No. 544, eff. 5-1-01; CR 07-099: cr. (2) (q), r. (3) (d) Register May 2008 No. 629, eff. 6-1-08.
Phar 7.02 Phar 7.02Prescription label; name of drug or drug product dispensed. No drug product may be dispensed unless the prescription label discloses the brand name and strength, or the generic name, strength, and manufacturer or distributor of the drug product dispensed unless the prescribing practitioner requests omission of the above information. If a pharmacist, pursuant to a prescription order that specifies a drug product by its brand name, dispenses the drug product equivalent of the drug product specified in the prescription order, the prescription label may include both the generic name of the drug product equivalent and the brand name specified in the prescription order, unless the prescribing practitioner requests that the brand name be omitted from the label. If a brand name drug product is dispensed, the prescription label may contain both the brand name and the generic name of the drug product equivalent dispensed unless the prescribing practitioner requests that the generic name of the drug product equivalent be omitted from the label.
Phar 7.02 History History: Cr. Register, January, 1983, No. 325, eff. 2-1-83; Register, August, 1991, No. 428, eff. 9-1-91; am. Register, January, 1996, No. 481, eff. 2-1-96; CR 07-097: am. Register May 2008 No. 629, eff. 6-1-08.
Phar 7.03 Phar 7.03Prescription renewal limitations. A prescription order for any drug other than controlled substances, which bears renewal authorization permitting the pharmacist to renew the prescription as needed (PRN) by the patient, shall not be renewed beyond one year from the date originally prescribed. No prescription order containing either specific or PRN renewal authorization is valid after the patient-physician relationship has ceased.
Phar 7.03 History History: Cr. Register, January, 1983, No. 325, eff. 2-1-83; Register, August, 1991, No. 428, eff. 9-1-91.
Phar 7.04 Phar 7.04Return or exchange of health items.
Phar 7.04(1) (1) In this section:
Phar 7.04(1)(a) (a) “Health item" means drugs, devices, hypodermic syringes, needles or other objects for injecting a drug, medicines, or items of personal hygiene.
Phar 7.04(1)(b) (b) “Inpatient health care facility" means any hospital, nursing home, county home, county mental hospital, tuberculosis sanitarium or similar facility, but does not include community-based residential facilities, jails or prison facilities.
Phar 7.04(1)(c) (c) “Original container" means the container in which a health item was sold, distributed or dispensed.
Phar 7.04(1)(d) (d) “Resident health care patient" means a patient residing in a community-based residential facility that controls a resident's prescribed and over-the-counter medications as specified by s. DHS 83.37
Phar 7.04(1)(e) (e) “Secured institutional health care patient" means any of the following:
Phar 7.04(1)(e)1. 1. A jail inmate patient whose dispensed health items are maintained under the custody and control of the jail pursuant to an approved policy and procedure manual under s. DOC 350.17, containing policies and procedures for the control and administration of medications complying with s. DOC 350.20.
Phar 7.04(1)(e)2. 2. A juvenile patient who resides in a juvenile correctional facility, as defined in s. 938.02 (10p), Stats.; a secured residential care center for children and youth, as defined in s. 938.02 (15g), Stats.; a juvenile detention facility, as defined in s. 938.02 (10r), Stats.; or a juvenile portion of a county jail whose dispensed health items are maintained under the custody and control of the health services staff as defined in s. DOC 316.02 (6) and provided to a juvenile patient under the provisions of s. DOC 316.03.
Phar 7.04(1)(f) (f) “Tamper-resistant package" means a container bearing a beyond use date that is sealed so that the contents cannot be used without obvious destruction of the seal.
Phar 7.04(2) (2) No health items after taken from a pharmacy where sold, distributed or dispensed, may be returned to that pharmacy, except for any of the following:
Phar 7.04(2)(a) (a) From an inpatient health care facility, provided they are in their original containers and the pharmacist determines the contents are not adulterated or misbranded.
Phar 7.04(2)(b) (b) Where the health items were dispensed in error, were defective, adulterated, misbranded, or dispensed beyond their beyond use date.
Phar 7.04(2)(c) (c) When in the professional judgment of the pharmacist substantial harm could result to the public or a patient if they were to remain in the possession of the patient, patient's family or agent, or other person.
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.